U.S. Department of Health & Human Services
Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report
Institute for Clinical and Economic Review, issuing body. Midwest Comparative Effectiveness Public Advisory Council, issuing body.
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 20, 2018
Antibodies, Monoclonal -- therapeutic use
Asthma -- drug therapy
Inflammation -- drug therapy
Antibodies, Monoclonal -- adverse effects
Antibodies, Monoclonal -- economics
Hypersensitivity -- drug therapy
Inflammation -- complications
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license.
1 online resource (1 PDF file (1 (various pagings))
NLM Unique ID:
See catalog record
Metadata (Dublin Core)